{"entity":{"type":"insider","cik":"0001533451","url":"/insider/0001533451","json_url":"/insider/0001533451.json","name":"Hoerter Steven L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":19,"first":"2013-06-06","last":"2025-10-20","span_basis":"filed_date"},"name_variants":[{"name":"Hoerter Steven L.","source":"filing","n_filings":19,"first_seen":"2013-06-06","last_seen":"2025-10-20"}],"transactions":[{"id":5108060,"accession":"0001193125-25-243653","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-243653","line_url":"/filing/0001193125-25-243653#line-1","is_derivative":false,"issuer_cik":"0001533451","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001533451","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":13.2492,"price_display":"13.25","price_state":"stated","total_value":264984.0,"total_display":"264,984.00","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-20","scope":"insider"},{"id":8750152,"accession":"0000950170-23-070386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-070386","line_url":"/filing/0000950170-23-070386#line-2","is_derivative":false,"issuer_cik":"0001533451","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001533451","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30664.0,"shares_display":"30,664","price_per_share":15.3671,"price_display":"15.37","price_state":"stated","total_value":471216.7544,"total_display":"471,216.75","shares_owned_after":72763.0,"shares_owned_after_display":"72,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-14","scope":"insider"},{"id":8335336,"accession":"0001209191-23-053935","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-053935","line_url":"/filing/0001209191-23-053935#line-2","is_derivative":false,"issuer_cik":"0001533451","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001533451","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21573.0,"shares_display":"21,573","price_per_share":12.0176,"price_display":"12.02","price_state":"stated","total_value":259255.6848,"total_display":"259,255.68","shares_owned_after":40927.0,"shares_owned_after_display":"40,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-30","filed_date":"2023-10-31","scope":"insider"},{"id":7918189,"accession":"0001209191-23-020720","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-020720","line_url":"/filing/0001209191-23-020720#line-1","is_derivative":false,"issuer_cik":"0001533451","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001533451","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":15.5709,"price_display":"15.57","price_state":"stated","total_value":116781.75,"total_display":"116,781.75","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-03-23","scope":"insider"},{"id":8035004,"accession":"0001209191-23-010062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-010062","line_url":"/filing/0001209191-23-010062#line-1","is_derivative":false,"issuer_cik":"0001533451","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001533451","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30045.0,"shares_display":"30,045","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":480720.0,"total_display":"480,720.00","shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-16","scope":"insider"},{"id":8451472,"accession":"0001209191-19-016381","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-016381","line_url":"/filing/0001209191-19-016381#line-4","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":68.0,"price_display":"68.00","price_state":"stated","total_value":340000.0,"total_display":"340,000.00","shares_owned_after":10941.0,"shares_owned_after_display":"10,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-05","scope":"insider"},{"id":8451465,"accession":"0001209191-19-016381","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-016381","line_url":"/filing/0001209191-19-016381#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":66.01,"price_display":"66.01","price_state":"stated","total_value":330050.0,"total_display":"330,050.00","shares_owned_after":10941.0,"shares_owned_after_display":"10,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-05","scope":"insider"},{"id":6237490,"accession":"0001209191-18-048672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-048672","line_url":"/filing/0001209191-18-048672#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2050.0,"shares_display":"2,050","price_per_share":74.92,"price_display":"74.92","price_state":"stated","total_value":153586.0,"total_display":"153,586.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-24","filed_date":"2018-08-28","scope":"insider"},{"id":6559220,"accession":"0001209191-18-044183","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-044183","line_url":"/filing/0001209191-18-044183#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2050.0,"shares_display":"2,050","price_per_share":84.58,"price_display":"84.58","price_state":"stated","total_value":173389.0,"total_display":"173,389.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-25","filed_date":"2018-07-27","scope":"insider"},{"id":6605374,"accession":"0001209191-18-039501","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-039501","line_url":"/filing/0001209191-18-039501#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2050.0,"shares_display":"2,050","price_per_share":97.58,"price_display":"97.58","price_state":"stated","total_value":200039.0,"total_display":"200,039.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-22","filed_date":"2018-06-26","scope":"insider"},{"id":5999769,"accession":"0001209191-18-033648","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-033648","line_url":"/filing/0001209191-18-033648#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2050.0,"shares_display":"2,050","price_per_share":85.76,"price_display":"85.76","price_state":"stated","total_value":175808.0,"total_display":"175,808.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-23","filed_date":"2018-05-29","scope":"insider"},{"id":6861248,"accession":"0001209191-18-026071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-026071","line_url":"/filing/0001209191-18-026071#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2050.0,"shares_display":"2,050","price_per_share":85.95,"price_display":"85.95","price_state":"stated","total_value":176197.5,"total_display":"176,197.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-25","scope":"insider"},{"id":6420857,"accession":"0001209191-18-021611","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-021611","line_url":"/filing/0001209191-18-021611#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2050.0,"shares_display":"2,050","price_per_share":84.65,"price_display":"84.65","price_state":"stated","total_value":173532.5,"total_display":"173,532.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-22","filed_date":"2018-03-26","scope":"insider"},{"id":6197691,"accession":"0001209191-18-013400","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-013400","line_url":"/filing/0001209191-18-013400#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2050.0,"shares_display":"2,050","price_per_share":78.63,"price_display":"78.63","price_state":"stated","total_value":161191.5,"total_display":"161,191.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-22","filed_date":"2018-02-26","scope":"insider"},{"id":6011537,"accession":"0001209191-18-005360","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-005360","line_url":"/filing/0001209191-18-005360#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":74.83,"price_display":"74.83","price_state":"stated","total_value":1870750.0,"total_display":"1,870,750.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-23","filed_date":"2018-01-25","scope":"insider"},{"id":8745692,"accession":"0001209191-15-024245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-024245","line_url":"/filing/0001209191-15-024245#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":1600000.0,"total_display":"1,600,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-09","scope":"insider"},{"id":8246664,"accession":"0001209191-15-016049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-016049","line_url":"/filing/0001209191-15-016049#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":72.0,"price_display":"72.00","price_state":"stated","total_value":720000.0,"total_display":"720,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-19","scope":"insider"},{"id":8792208,"accession":"0001209191-15-005340","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-005340","line_url":"/filing/0001209191-15-005340#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":67.0,"price_display":"67.00","price_state":"stated","total_value":670000.0,"total_display":"670,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-16","filed_date":"2015-01-20","scope":"insider"},{"id":8919682,"accession":"0001209191-15-004402","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-004402","line_url":"/filing/0001209191-15-004402#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":62.0,"price_display":"62.00","price_state":"stated","total_value":620000.0,"total_display":"620,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-13","filed_date":"2015-01-15","scope":"insider"},{"id":5467677,"accession":"0001181431-13-033305","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-033305","line_url":"/filing/0001181431-13-033305#line-2","is_derivative":false,"issuer_cik":"0001466301","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001466301","owner_cik":"0001533451","owner_name":"Hoerter Steven L.","owner_url":"/insider/0001533451","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":73.06,"price_display":"73.06","price_state":"stated","total_value":730600.0,"total_display":"730,600.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-04","filed_date":"2013-06-06","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001776111","name":"MBX Biosciences, Inc.","url":"/issuer/0001776111","role":"Director","n_filings":1,"first_seen":"2025-10-20","last_seen":"2025-10-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001654151","name":"Deciphera Pharmaceuticals, Inc.","url":"/issuer/0001654151","role":"Director, Officer (President and CEO)","n_filings":4,"first_seen":"2023-02-16","last_seen":"2023-12-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS INC","url":"/issuer/0001439222","role":"Officer (Chief Commercial Officer)","n_filings":9,"first_seen":"2018-01-25","last_seen":"2019-03-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Officer","n_filings":5,"first_seen":"2013-06-06","last_seen":"2015-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001533451","retrieved_at":"2026-08-22T04:09:50+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}